Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Mineralys Therapeutics, Inc.
MLYS
Other
Rsu Psu Vesting Schedule Disclosed
Classified Board Director Election
Other
Change Of Control Definition
New York Jurisdiction Clause
Net Loss Reported
Cash Flow Statement Investing Activities
Restrictive Debt Covenants Disclosure
Amendment Modification Waiver Clause
Financing Activities Cash Flow Disclosure
Arbitrator Selection Procedure
Fcpa Compliance Representation
Liquidity Position Snapshot Disclosed
Sanctions Compliance Representation
Incorporation Or Reincorporation Disclosure
Capital Raising Uncertainty Disclosed
Libor Based Term Loan Pricing
Shares Outstanding Disclosure
Other
Net Loss Reported
Liquidity Position Snapshot Disclosed
Priority Review Or Pdufa Disclosed
Amendment Modification Waiver Clause
New York Jurisdiction Clause
Earnings Call Replay Details
Kol Endorsement
Enrollment Ahead Of Schedule
Personnel Cost Decrease Disclosure
Interim Data Positive
Equity Plan Board Approval Conditional On Shareholder Vote
Core
Near Term Regulatory Decision
Indication Expansion
Lead Asset Progress
Clinical Trial Result
Other
New York Jurisdiction Clause
Fcpa Compliance Representation
Ipo Net Proceeds Disclosure
Sanctions Compliance Representation
Corporate Organization And Standing Representation
Use Of Proceeds Disclosure
Director Officer Indemnification Provision
Form S3 Shelf Registration Disclosure
Legal Opinion Methodology Disclosure
No Regulatory Approval Required
Closing Condition Opinions And Certificates
Registration Rights Piggyback Provision
Corporate Authority Representation
Conflicted Defense Counsel Provision
Prospectus Supplement Disclosure
Other
Restrictive Debt Covenants Disclosure
Libor Based Term Loan Pricing
Event Of Default Defined
Term Loan B Holding Disclosure
Other
Auditor Appointment Ratification
Classified Board Director Election
Other
Net Loss Reported
Liquidity Position Snapshot Disclosed
Priority Review Or Pdufa Disclosed
Personnel Cost Decrease Disclosure
Kol Endorsement
Earnings Call Replay Details
Interim Data Positive
Enrollment Ahead Of Schedule
Burn Rate Controlled
Core
Lead Asset Progress
Clinical Trial Result
Indication Expansion
Near Term Regulatory Decision